| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/10/23 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 01/23/23 | 8-K | Current report filing |
|
   |
3 |
| 01/18/23 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |
| 01/17/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
28 |
| 01/17/23 | 8-K | Current report filing |
|
|
15 |
| 12/29/22 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/28/22 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
20 | |
| 12/22/22 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/21/22 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
20 | |
| 12/06/22 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
8 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.